Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Argan (AGX) Financials

Argan logo
$654.99 +10.35 (+1.61%)
Closing price 03:59 PM Eastern
Extended Trading
$660.08 +5.09 (+0.78%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Argan

Annual Income Statements for Argan

This table shows Argan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 36 70 72 52 -43 24 38 33 32 83 145
Consolidated Net Income / (Loss)		 50 77 72 52 -41 24 36 35 32 85 138
Net Income / (Loss) Continuing Operations		 50 77 72 52 -41 24 36 35 32 85 138
Total Pre-Tax Income 		76 115 113 47 -48 25 47 46 49 111 161
Total Operating Income		 74 112 107 40 -56 23 45 42 36 88 135
Total Gross Profit		 99 147 149 82 -6.82 62 100 86 81 141 194
Total Revenue		 413 675 893 482 239 392 509 455 573 874 945
Operating Revenue		 413 675 893 482 239 392 509 455 573 874 945
Total Cost of Revenue		 314 528 743 400 246 330 410 369 492 733 751
Operating Cost of Revenue		 314 528 743 400 246 330 410 369 492 733 751
Total Operating Expenses		 25 34 42 42 49 39 55 45 44 53 59
Selling, General & Admin Expense		 25 32 42 41 44 39 47 45 44 53 59
Total Other Income / (Expense), net		 1.10 2.28 5.65 6.98 8.08 1.86 2.55 4.33 12 23 26
Other Income / (Expense), net		 1.10 2.28 5.65 6.98 8.08 1.86 2.55 4.33 12 23 26
Income Tax Expense		 25 37 40 -4.65 -7.05 1.07 11 11 17 26 23
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 - - - - - - 0.00 0.00 0.72 2.94 -7.36
Basic Earnings per Share		 $2.46 $4.67 $4.64 $3.34 ($2.73) $1.52 $2.43 $2.35 $2.42 $6.35 $10.00
Weighted Average Basic Shares Outstanding		 14.76M 15.07M 15.52M 15.57M 15.62M 15.67M 15.72M 14.08M 13.37M 13.45M 13.77M
Diluted Earnings per Share		 $2.42 $4.50 $4.56 $3.32 ($2.73) $1.51 $2.40 $2.33 $2.39 $6.15 $9.74
Weighted Average Diluted Shares Outstanding		 15.02M 15.63M 15.78M 15.69M 15.62M 15.83M 15.91M 14.18M 13.55M 13.91M 14.15M
Weighted Average Basic & Diluted Shares Outstanding		 14.80M 15.10M 15.50M 15.60M 15.64M 15.72M 14.82M 13.40M 13.24M 13.63M 13.95M
Cash Dividends to Common per Share		 $0.70 $1.00 $1.00 $1.00 $1.00 $3.00 $1.00 $1.00 $1.10 $1.35 $1.75

Quarterly Income Statements for Argan

This table shows Argan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 12 4.16 14 6.12 19 26 33 29 34 32 50
Consolidated Net Income / (Loss)		 13 5.46 12 7.88 18 28 31 23 35 31 49
Net Income / (Loss) Continuing Operations		 13 5.46 12 7.88 18 28 31 23 35 31 49
Total Pre-Tax Income 		17 12 17 11 24 37 39 30 36 40 55
Total Operating Income		 13 7.86 12 6.52 19 30 33 24 30 33 48
Total Gross Profit		 24 19 24 18 31 44 48 37 44 47 66
Total Revenue		 141 164 165 158 227 257 232 194 238 251 262
Operating Revenue		 141 164 165 158 227 257 232 194 238 251 262
Total Cost of Revenue		 118 145 141 140 196 213 185 157 193 204 196
Operating Cost of Revenue		 118 145 141 140 196 213 185 157 193 204 196
Total Operating Expenses		 11 11 12 11 12 14 15 13 14 14 18
Selling, General & Admin Expense		 11 11 12 11 12 14 15 13 14 14 18
Total Other Income / (Expense), net		 4.12 3.73 5.25 4.79 5.60 6.65 5.97 5.44 5.58 7.06 7.72
Other Income / (Expense), net		 4.12 3.73 5.25 4.79 5.60 6.65 5.97 5.44 5.58 7.06 7.72
Income Tax Expense		 4.59 6.13 4.96 3.43 6.08 8.97 7.26 7.24 0.36 8.96 6.18
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)		 0.87 1.31 -1.97 1.76 -1.27 1.62 -1.48 -6.30 1.33 -1.46 -0.93
Basic Earnings per Share		 $0.95 $0.41 $0.90 $0.59 $1.36 $2.07 $2.33 $1.65 $2.57 $2.22 $3.56
Weighted Average Basic Shares Outstanding		 13.40M 13.33M 13.37M 13.26M 13.40M 13.53M 13.45M 13.63M 13.73M 13.83M 13.77M
Diluted Earnings per Share		 $0.94 $0.40 $0.89 $0.58 $1.31 $2.00 $2.26 $1.60 $2.50 $2.17 $3.47
Weighted Average Diluted Shares Outstanding		 13.54M 13.56M 13.55M 13.57M 13.88M 14.03M 13.91M 14.11M 14.13M 14.16M 14.15M
Weighted Average Basic & Diluted Shares Outstanding		 13.32M 13.33M 13.24M 13.35M 13.50M 13.58M 13.63M 13.64M 13.81M 13.87M 13.95M
Cash Dividends to Common per Share		 $0.25 $0.30 $0.30 $0.30 $0.30 $0.38 $0.38 $0.38 $0.38 $0.50 $0.50

Annual Cash Flow Statements for Argan

This table details how cash moves in and out of Argan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Change in Cash & Equivalents		 -173 6.37 -48 43 3.05 199 -16 -177 23 -52 194
Net Cash From Operating Activities		 -33 259 -73 -112 54 176 28 -30 117 168 415
Net Cash From Continuing Operating Activities		 -33 259 -73 -112 54 176 28 -30 117 168 415
Net Income / (Loss) Continuing Operations		 50 77 72 52 -41 24 36 35 32 85 138
Consolidated Net Income / (Loss)		 50 77 72 52 -41 24 36 35 32 85 138
Depreciation Expense		 0.78 2.04 2.78 3.42 3.51 3.72 3.37 2.98 2.01 1.91 1.91
Amortization Expense		 0.53 1.16 1.03 1.01 1.14 0.90 0.87 2.55 1.91 3.76 4.26
Non-Cash Adjustments To Reconcile Net Income		 2.23 118 -131 -42 34 12 39 -16 -18 25 -8.77
Changes in Operating Assets and Liabilities, net		 -87 60 -18 -127 56 136 -51 -54 99 51 280
Net Cash From Investing Activities		 -131 -244 39 171 -36 67 -7.04 -63 -68 -194 -182
Net Cash From Continuing Investing Activities		 -131 -244 39 171 -36 67 -7.04 -63 -68 -194 -182
Purchase of Property, Plant & Equipment		 -3.12 -2.81 -4.83 -8.60 -7.06 -1.70 -1.42 -3.37 -2.76 -6.58 -3.88
Acquisitions		 -17 - - - 0.00 -1.33 -5.62 0.00 -5.11 -16 -12
Purchase of Investments		 -252 -595 -543 -191 -195 -100 -90 -250 -219 -315 -377
Sale and/or Maturity of Investments		 138 354 588 370 166 170 90 190 160 149 210
Other Investing Activities, net		 3.96 - -1.50 0.23 - - - 0.00 0.00 -5.02 0.00
Net Cash From Financing Activities		 -8.65 -8.86 -14 -16 -14 -45 -35 -83 -26 -26 -43
Net Cash From Continuing Financing Activities		 -8.65 -8.86 -14 -16 -14 -45 -35 -83 -26 -26 -43
Repurchase of Common Equity		 - - - - 0.00 0.00 -20 -68 -12 -1.52 -9.88
Payment of Dividends		 -10 -25 -17 -16 -16 -47 -16 -15 -15 -18 -24
Other Financing Activities, net		 1.73 16 3.16 0.10 1.63 1.64 1.43 0.07 1.10 -6.27 -8.44
Effect of Exchange Rate Changes		 -0.57 - - - -0.47 1.73 -2.97 -0.54 -0.12 0.32 4.11
Cash Income Taxes Paid		 26 37 44 - - - 14 6.67 14 31 30

Quarterly Cash Flow Statements for Argan

This table details how cash moves in and out of Argan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
Net Change in Cash & Equivalents		 8.85 -19 11 11 25 -57 -30 44 -11 128 33
Net Cash From Operating Activities		 36 58 25 18 73 32 45 35 35 172 172
Net Cash From Continuing Operating Activities		 36 58 25 18 73 32 45 35 35 172 172
Net Income / (Loss) Continuing Operations		 13 5.46 12 7.88 18 28 31 23 35 31 49
Consolidated Net Income / (Loss)		 13 5.46 12 7.88 18 28 31 23 35 31 49
Depreciation Expense		 0.49 0.49 0.49 0.48 0.46 0.43 0.53 0.42 0.49 0.51 0.50
Amortization Expense		 0.10 0.10 1.61 0.65 0.10 0.10 3.46 1.17 0.98 0.94 1.17
Non-Cash Adjustments To Reconcile Net Income		 -14 -2.87 -23 -4.93 11 3.65 15 -1.75 8.86 -13 -2.47
Changes in Operating Assets and Liabilities, net		 37 55 33 14 44 -0.41 -5.59 13 -11 154 124
Net Cash From Investing Activities		 -20 -70 -5.72 -1.73 -43 -82 -67 25 -39 -37 -131
Net Cash From Continuing Investing Activities		 -20 -70 -5.72 -1.73 -43 -82 -67 25 -39 -37 -131
Purchase of Property, Plant & Equipment		 -0.39 -1.11 -0.61 -0.32 -2.35 -2.55 -1.37 -0.40 -1.69 -0.58 -1.21
Purchase of Investments		 -30 -69 - -87 -55 -102 -70 -40 -77 -85 -174
Sale and/or Maturity of Investments		 10 - - 89 15 23 23 65 40 60 45
Net Cash From Financing Activities		 -6.00 -5.56 -8.00 -5.12 -5.56 -6.93 -8.45 -18 -6.93 -7.52 -10
Net Cash From Continuing Financing Activities		 -6.00 -5.56 -8.00 -5.12 -5.56 -6.93 -8.45 -18 -6.93 -7.52 -10
Repurchase of Common Equity		 -3.06 -1.73 -4.00 -0.19 - -0.46 -0.88 -6.85 -0.20 - -2.83
Payment of Dividends		 -3.34 -3.99 -4.00 -4.03 -4.04 -5.20 -5.01 -5.07 -5.18 -7.05 -6.98
Other Financing Activities, net		 0.40 0.16 -0.01 -0.91 -1.52 -1.28 -2.56 -6.08 -1.55 -0.47 -0.34
Effect of Exchange Rate Changes		 -0.66 -1.04 0.59 -0.13 -0.15 0.10 0.51 1.78 0.09 0.61 1.63
Cash Income Taxes Paid		 2.76 3.75 7.28 3.31 5.83 6.00 16 0.01 8.02 19 2.14

Annual Balance Sheets for Argan

This table presents Argan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Total Assets		 410 644 543 477 488 603 554 489 598 836 1,186
Total Current Assets		 351 588 485 416 422 546 507 439 547 781 1,132
Cash & Equivalents		 161 167 122 164 167 367 350 174 197 145 339
Short-Term Investments		 114 356 312 132 160 90 90 152 215 380 556
Accounts Receivable		 64 55 26 36 37 29 27 50 47 176 134
Other Current Assets		 4.08 3.19 25 84 57 61 40 63 87 80 104
Plant, Property, & Equipment, net		 12 13 15 20 23 20 10 10 11 14 17
Total Noncurrent Assets		 47 43 42 41 43 36 32 40 40 40 38
Goodwill		 37 35 34 33 28 28 28 28 28 28 28
Intangible Assets		 9.34 8.18 7.15 6.14 5.00 4.10 3.32 2.61 2.22 1.83 1.45
Noncurrent Deferred & Refundable Income Taxes		 - 0.24 0.44 1.26 7.89 0.25 0.46 3.69 2.26 0.55 0.00
Other Noncurrent Operating Assets		 0.12 0.09 0.43 0.29 2.41 3.76 - 6.02 7.52 10 8.02
Total Liabilities & Shareholders' Equity		 410 644 543 477 488 603 554 489 598 836 1,186
Total Liabilities		 188 352 185 82 147 280 228 209 307 484 724
Total Current Liabilities		 188 351 183 81 144 276 223 203 302 480 711
Accounts Payable		 46 102 100 40 35 53 42 56 39 97 108
Accrued Expenses		 35 40 35 33 36 51 53 50 82 83 90
Other Current Liabilities		 - - 48 8.35 73 172 128 96 181 299 514
Total Noncurrent Liabilities		 0.22 1.20 1.28 0.96 2.48 4.14 4.96 6.09 5.03 4.51 13
Noncurrent Deferred & Payable Income Tax Liabilities		 0.22 1.20 1.28 - - - - - - 0.00 6.56
Other Noncurrent Operating Liabilities		 - - - 0.96 2.48 4.14 - 6.09 5.03 4.51 6.28
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 222 293 358 394 341 322 326 281 291 352 462
Total Preferred & Common Equity		 219 292 358 395 339 321 326 281 291 352 462
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 219 292 358 395 339 321 326 281 291 352 462
Common Stock		 120 138 146 147 151 156 161 165 167 171 170
Retained Earnings		 100 155 211 248 189 166 189 208 226 293 406
Treasury Stock		 - - - - - -0.03 -20 -89 -98 -106 -114
Accumulated Other Comprehensive Income / (Loss)		 -0.57 -0.76 1.42 -0.35 -1.12 -1.08 -2.45 -2.88 -3.60 -6.54 0.82

Quarterly Balance Sheets for Argan

This table presents Argan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 7/31/2022 10/31/2022 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024 4/30/2025 7/31/2025 10/31/2025
Total Assets		 423 411 476 506 564 624 727 769 792 883 1,051
Total Current Assets		 378 365 425 455 514 574 675 717 738 829 997
Cash & Equivalents		 143 136 196 205 186 208 233 175 189 178 306
Short-Term Investments		 176 151 121 142 212 209 252 331 357 394 421
Accounts Receivable		 25 38 61 45 50 60 95 132 106 179 170
Other Current Assets		 34 40 47 64 67 98 95 79 85 77 100
Plant, Property, & Equipment, net		 9.51 11 11 10 11 11 12 14 15 16 16
Total Noncurrent Assets		 35 35 40 40 39 39 40 38 40 38 38
Goodwill		 28 28 28 28 28 28 28 28 28 28 28
Intangible Assets		 2.94 2.73 2.51 2.41 2.32 2.12 2.02 1.92 1.73 1.63 1.53
Noncurrent Deferred & Refundable Income Taxes		 4.40 4.67 3.61 3.91 3.13 2.31 1.64 1.25 0.00 0.00 0.00
Other Noncurrent Operating Assets		 - - 5.88 5.76 5.32 6.80 7.83 6.37 9.81 8.54 8.36
Total Liabilities & Shareholders' Equity		 423 411 476 506 564 624 727 769 792 883 1,051
Total Liabilities		 146 139 198 221 279 331 419 440 428 490 631
Total Current Liabilities		 142 135 192 216 274 328 415 436 423 484 620
Accounts Payable		 38 45 36 32 35 66 100 87 69 96 101
Accrued Expenses		 40 40 45 68 83 61 62 78 70 71 67
Other Current Liabilities		 64 49 111 116 156 200 254 271 284 317 452
Total Noncurrent Liabilities		 4.02 4.62 5.35 5.07 4.93 3.66 3.38 4.00 5.31 5.21 11
Noncurrent Deferred & Payable Income Tax Liabilities		 - - - - - - - - 0.67 0.74 6.12
Other Noncurrent Operating Liabilities		 4.02 - 5.35 5.07 4.93 3.66 3.38 4.00 4.64 4.46 5.18
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 277 272 278 285 285 293 308 329 364 393 420
Total Preferred & Common Equity		 278 273 278 285 285 293 308 329 364 393 420
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 278 273 278 285 285 293 308 329 364 393 420
Common Stock		 163 164 164 165 166 167 168 171 168 169 169
Retained Earnings		 193 198 207 216 217 229 244 266 310 340 364
Treasury Stock		 -74 -84 -90 -92 -94 -98 -100 -103 -114 -115 -114
Accumulated Other Comprehensive Income / (Loss)		 -4.40 -5.05 -2.47 -3.34 -4.65 -5.36 -4.08 -5.70 -0.24 -1.57 -0.11

Annual Metrics And Ratios for Argan

This table displays calculated financial ratios and metrics derived from Argan's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2016 1/31/2017 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 13,873,410.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 13,873,410.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 10.46
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 49 76 69 44 -39 22 34 31 24 68 116
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 11.19% 8.29% 19.26% 25.01%
Earnings before Interest and Taxes (EBIT)		 76 115 113 47 -48 25 47 46 49 111 161
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 77 118 116 52 -43 30 51 52 53 117 167
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -56 253 -86 -130 46 170 13 -38 101 120 375
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -53 -230 -76 98 13 -134 -114 -45 -121 -173 -433
Increase / (Decrease) in Invested Capital		 106 -177 155 174 -85 -147 20 69 -77 -52 -259
Book Value per Share		 $14.74 $19.05 $23.03 $25.34 $21.70 $20.44 $20.77 $20.69 $21.83 $25.92 $33.32
Tangible Book Value per Share		 $11.59 $16.24 $20.36 $22.84 $19.59 $18.40 $18.77 $18.43 $19.56 $23.72 $31.19
Total Capital		 222 293 358 394 341 322 326 281 291 352 462
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -275 -523 -434 -297 -328 -457 -440 -325 -412 -525 -895
Capital Expenditures (CapEx)		 3.12 2.81 4.83 8.60 7.06 1.70 1.42 3.37 2.76 6.58 3.88
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -112 -286 -132 39 -50 -187 -156 -89 -167 -224 -474
Debt-free Net Working Capital (DFNWC)		 163 237 302 335 278 270 284 236 245 301 421
Net Working Capital (NWC)		 163 237 302 335 278 270 284 236 245 301 421
Net Nonoperating Expense (NNE)		 -0.73 -1.54 -3.63 -7.67 1.62 -1.78 -1.94 -3.27 -8.25 -18 -22
Net Nonoperating Obligations (NNO)		 -275 -523 -434 -297 -328 -457 -440 -325 -412 -525 -895
Total Depreciation and Amortization (D&A)		 1.31 3.21 3.81 4.43 4.65 4.62 4.24 5.54 3.92 5.66 6.17
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $2.46 $4.67 $4.64 $3.34 ($2.73) $1.52 $2.43 $2.35 $2.42 $6.35 $10.00
Adjusted Weighted Average Basic Shares Outstanding		 14.76M 15.07M 15.52M 15.57M 15.62M 15.67M 15.72M 14.08M 13.37M 13.45M 13.77M
Adjusted Diluted Earnings per Share		 $2.42 $4.50 $4.56 $3.32 ($2.73) $1.51 $2.40 $2.33 $2.39 $6.15 $9.74
Adjusted Weighted Average Diluted Shares Outstanding		 15.02M 15.63M 15.78M 15.69M 15.62M 15.83M 15.91M 14.18M 13.55M 13.91M 14.15M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 14.84M 15.47M 15.57M 15.58M 15.64M 15.72M 14.82M 13.40M 13.24M 13.63M 13.95M
Normalized Net Operating Profit after Tax (NOPAT)		 49 77 69 29 -36 22 40 31 24 68 116
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Quarterly Metrics And Ratios for Argan

This table displays calculated financial ratios and metrics derived from Argan's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 7/31/2023 10/31/2023 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026
DEI Shares Outstanding		 - - - - - - - - - - 13,873,410.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - - 13,873,410.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - - 3.61
Growth Metrics		 - - - - - - - - - - -
Profitability Metrics		 - - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)		 9.74 3.70 8.30 4.54 14 23 27 18 30 25 42
Return On Investment Capital (ROIC_SIMPLE)		 - - 2.85% - - - 7.54% 5.06% 7.57% 6.02% 9.16%
Earnings before Interest and Taxes (EBIT)		 17 12 17 11 24 37 39 30 36 40 55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 18 12 19 12 25 38 43 31 37 41 57
Valuation Ratios		 - - - - - - - - - - -
Leverage & Solvency		 - - - - - - - - - - -
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 29 106 85 89 129 88 78 78 32 155 302
Efficiency Ratios		 - - - - - - - - - - -
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -61 -113 -121 -123 -177 -178 -173 -183 -179 -307 -433
Increase / (Decrease) in Invested Capital		 -19 -102 -77 -84 -115 -65 -52 -59 -2.40 -130 -259
Book Value per Share		 $21.25 $21.39 $21.83 $22.14 $23.07 $24.35 $25.92 $26.69 $28.82 $30.39 $33.32
Tangible Book Value per Share		 $18.98 $19.11 $19.56 $19.86 $20.82 $22.13 $23.72 $24.51 $26.65 $28.25 $31.19
Total Capital		 285 285 291 293 308 329 352 364 393 420 462
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -346 -398 -412 -416 -485 -506 -525 -546 -572 -727 -895
Capital Expenditures (CapEx)		 0.39 1.11 0.61 0.32 2.35 2.55 1.37 0.40 1.69 0.58 1.21
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -107 -157 -167 -170 -225 -225 -224 -231 -228 -350 -474
Debt-free Net Working Capital (DFNWC)		 240 240 245 247 260 281 301 315 344 377 421
Net Working Capital (NWC)		 240 240 245 247 260 281 301 315 344 377 421
Net Nonoperating Expense (NNE)		 -3.03 -1.76 -3.72 -3.34 -4.20 -5.03 -4.84 -4.12 -5.52 -5.47 -6.86
Net Nonoperating Obligations (NNO)		 -346 -398 -412 -416 -485 -506 -525 -546 -572 -727 -895
Total Depreciation and Amortization (D&A)		 0.59 0.59 2.10 0.58 0.56 0.53 3.99 1.59 1.47 1.45 1.67
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.95 $0.41 $0.90 $0.59 $1.36 $2.07 $2.33 $1.65 $2.57 $2.22 $3.56
Adjusted Weighted Average Basic Shares Outstanding		 13.40M 13.33M 13.37M 13.26M 13.40M 13.53M 13.45M 13.63M 13.73M 13.83M 13.77M
Adjusted Diluted Earnings per Share		 $0.94 $0.40 $0.89 $0.58 $1.31 $2.00 $2.26 $1.60 $2.50 $2.17 $3.47
Adjusted Weighted Average Diluted Shares Outstanding		 13.54M 13.56M 13.55M 13.57M 13.88M 14.03M 13.91M 14.11M 14.13M 14.16M 14.15M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 13.32M 13.33M 13.24M 13.35M 13.50M 13.58M 13.63M 13.64M 13.81M 13.87M 13.95M
Normalized Net Operating Profit after Tax (NOPAT)		 9.74 5.50 8.30 4.54 14 23 27 18 30 25 42
Debt Service Ratios		 - - - - - - - - - - -
Payout Ratios		 - - - - - - - - - - -

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways for Argan Inc (NYSE: AGX) based on the last four calendar years of quarterly statements (2023–2026). The focus is on trends in revenue, profitability, cash flow, and balance-sheet strength.

  • Strong top‑line growth and margin expansion in 2025–2026: Revenue rose from roughly 164.6M in Q4 2024 to 232.5–262.1M in 2025–2026 periods, with gross margin improving notably (e.g., gross profit of about 65.6M on 262.1M revenue in Q4 2026, vs substantially lower margins in 2024). This indicates a favorable mix and pricing progression.
  • Higher earnings and EPS in latest quarter: Q4 2026 net income attributable to common shareholders was about 50.1M, with basic EPS of 3.56 and diluted EPS of 3.47. This represents meaningful year‑over‑year earnings growth and improved profitability per share as the company scales.
  • Robust operating cash flow in 2025–2026: Net cash from continuing operating activities was strong in the recent quarters (for example, about 172.3M in Q4 2026 and around 172.5M in Q3 2026), highlighting solid cash generation from core operations.
  • Solid liquidity and a growing equity base: In the latest period, cash and cash equivalents were about 300M+, with ~420M in short‑term investments and total current assets near 1B, while total equity approached 420M. This combination supports balance-sheet resilience and potential capacity for strategic initiatives.
  • Substantial shareholder returns indicated by a quarterly dividend: Cash dividends per share show ongoing distributions (0.50 in Q4 2026, with smaller recent payouts in other quarters), which can be appealing to income‑focused investors when paired with strong earnings growth.
  • Diverse but cyclical capital allocation: 2025–2026 saw notable investing activity (purchases of investments and acquisitions in various quarters), which produced sizable negative cash flows from investing activities in some periods. This suggests a strategic shift toward investment diversification or growth initiatives, but it compresses near‑term free cash flow.
  • Revenue volatility across the four‑year window: After a dip in 2024, revenue recovered by 2025 and continued to grow in 2026, but quarterly results show variability likely tied to product mix or customer cycles. Investors should monitor whether the growth trajectory remains sustainable across demand cycles.
  • Rising near‑term liabilities in mid‑2026: Total current liabilities rose to around 620M by Q3 2026 from lower levels earlier in 2026, signaling increased short‑term obligations that warrant attention for working capital management and liquidity outlook.
  • Financing cash outflows persist in many periods: Net cash from financing activities was negative in several quarters (e.g., Q3 2026 and Q4 2026), reflecting ongoing dividend payments and other financing outflows which may cap cash build‑up from operations alone.
  • Significant investing activity impacting near‑term cash: Net cash from continuing investing activities was negative in several quarters (for example, substantial purchases of investments and acquisitions in 2025–2026), contributing to cash outflows despite strong operating cash flow. This could affect near‑term liquidity depending on investment timing and returns.
05/22/26 06:15 PM ETAI Generated. May Contain Errors.

Argan Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Argan's fiscal year ends in January. Their fiscal year 2026 ended on January 31, 2026.

Argan's net income appears to be on an upward trend, with a most recent value of $137.77 million in 2026, rising from $50.20 million in 2016. The previous period was $85.46 million in 2025. See where experts think Argan is headed by visiting Argan's forecast page.

Argan's total operating income in 2026 was $134.70 million, based on the following breakdown:
  • Total Gross Profit: $193.68 million
  • Total Operating Expenses: $58.98 million

Over the last 10 years, Argan's total revenue changed from $413.28 million in 2016 to $944.61 million in 2026, a change of 128.6%.

Argan's total liabilities were at $724.09 million at the end of 2026, a 49.5% increase from 2025, and a 285.3% increase since 2016.

In the past 10 years, Argan's cash and equivalents has ranged from $122.11 million in 2018 to $366.67 million in 2021, and is currently $339.48 million as of their latest financial filing in 2026.

Over the last 10 years, Argan's book value per share changed from 14.74 in 2016 to 33.32 in 2026, a change of 126.1%.


Related Companies

Financial statements for NYSE:AGX last updated on 3/29/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
The SpaceX supplier that shipped 5 billion chips to Starlink
When Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...
Weiss Ratings | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
June 12: Elon Musk’s “Day-One Retirement Plan.”
SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...
Brownstone Research | Sponsoredtc pixel
I don't think Wall Street will warn you in time
Wall Street insiders move early. Everyone else finds out later. That gap gets especially dangerous during a Ch...
Trend Labs | Sponsoredtc pixel